COVID-19 and Underlying Chronic Lung Disease: What Is Known About Risk and Managing Care

Patients with COVID-19 who have underlying chronic lung disease are at increased risk for developing severe illness. Pulmonologist Brian Southern, MD, recently authored a review article in Cleveland Clinic Journal of Medicine’s COVID-19 Curbside Consults series. In this article, he takes a closer look at what is known about ILD and sarcoidosis in the context of the pandemic and offers insights for managing care.

Socioeconomic Disparities and Outcomes in Patients With Sarcoidosis

Mild symptoms and a quick recovery are common in most cases of sarcoidosis, but a minority of patients have significant morbidity and impaired quality of life because of multiorgan involvement. A new Cleveland Clinic study examines association between income and sarcoidosis outcomes, after controlling for socioeconomic and disease-related factors.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy